Pooled analysis of safety data from clinical trials evaluating acalabrutinib monotherapy in mature B-cell malignanciesRichard R. Furman, Jeff P. Sharman, Jennifer R. Brown et al.|Leukemia|2021Cited by 62
Safety of acalabrutinib (Acala) monotherapy in hematologic malignancies: Pooled analysis from clinical trials.Richard R. Furman, Jeff P. Sharman, John C. Byrd et al.|Journal of Clinical Oncology|2020Cited by 11